Get the Finder app 🥳

Track your credit score, free


How to buy Avecho Biotechnology shares | A$0.007

Own Avecho Biotechnology shares in just a few minutes.


Fact checked

Avecho Biotechnology Limited is a biotechnology business based in Australia. Avecho Biotechnology shares (AVE) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.007 – a decrease of 12.5% over the previous week. Avecho Biotechnology has a trailing 12-month revenue of around $258,906.

How to buy shares in Avecho Biotechnology

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Avecho Biotechnology. Find the share by name or ticker symbol: AVE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avecho Biotechnology reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price of $0.007, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Avecho Biotechnology. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Avecho Biotechnology's share price?

Since the stock market crash in March caused by coronavirus, Avecho Biotechnology's share price has had significant positive movement.

Its last market close was $0.007, which is 50.00% up on its pre-crash value of $0.0035 and 250.00% up on the lowest point reached during the March crash when the shares fell as low as $0.002.

If you had bought $1,000 worth of Avecho Biotechnology shares at the start of February 2020, those shares would have been worth $625.00 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,750.00.

Avecho Biotechnology share price

Use our graph to track the performance of AVE stocks over time.

Avecho Biotechnology shares at a glance

Information last updated 2020-09-15.
Latest market closeAUDA$0.007
52-week rangeAUDA$0.002 - AUDA$0.0105
50-day moving average AUDA$0.0081
200-day moving average AUDA$0.0065
Target priceAUDA$1.72
PE ratio 16
Dividend yield N/A (0%)
Earnings per share (TTM) AUDA$0.001

Share Trading Account Offer

IG Share Trading Offer


Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

  • Brokerage - AU shares: From AUD 5 or 0.05%
  • Brokerage - US shares: USD 0
  • Sign-up process: Instant
  • Support - After hours: Yes
Go to site
More info

Important: Share trading carries risk of capital loss.


Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Data indicated here is updated regularly
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
Finder Award
IG Share Trading
AUD 8 or 0.1%
AUD 50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares, Forex, CFDs, Margin trading
Brokerage discount: $5 on Australian shares for active traders & $0 commission on US and global shares
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, forex and CFDs, plus get access to 24-hour customer support.
Bell Direct Share Trading
AUD 15 or 0.1%
ASX shares, mFunds
Special offer: Free ETF trades until September 30th when you join Bell Direct
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
Superhero share trading
$5 a trade
ASX shares
Trade ASX stocks and ETFs with a flat $5 brokerage fee and a low minimum investment of just $100.
CMC Markets Stockbroking
AUD 11 or 0.1%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, mFunds
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, managed funds, forex, commodities and cryptocurrencies, plus access up to 15 major global and Australian stock exchanges.
ANZ Share Investing
AUD 19.95
ASX shares, Global shares, Margin trading, Options trading
Earn 1 Qantas Point per AU$3 spent on brokerage fees on certain instruments.
Access Morningstar reports, company announcements and and live pricing via ANZ’s share investing platform. Available for desktop and mobile.
Westpac Online Investing Account
AUD 19.95 or 0.11%
AUD 63.50 per year on the global markets account
ASX shares, Global shares, Options trading, US shares

Compare up to 4 providers

Is it a good time to buy Avecho Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Avecho Biotechnology price performance over time

Historical closes compared with the last close of A$0.007

1 week (2020-09-11) -12.50%
1 month (2020-08-18) -12.50%
3 months (2020-06-18) -12.50%
6 months (2020-03-18) 250.00%
1 year (2019-09-18) 40.00%
2 years (2018-09-18) -70.83%
3 years (2017-09-18) -62.37%
5 years (2015-09-18) -52.05%

Is Avecho Biotechnology under- or over-valued?

Valuing Avecho Biotechnology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avecho Biotechnology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avecho Biotechnology's P/E ratio

Avecho Biotechnology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Avecho Biotechnology shares trade at around 16x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Avecho Biotechnology's EBITDA

Avecho Biotechnology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 million (£634,218).

The EBITDA is a measure of a Avecho Biotechnology's overall financial performance and is widely used to measure a its profitability.

Avecho Biotechnology financials

Revenue TTM $258,906
Gross profit TTM $4 million
Return on assets TTM -32.96%
Return on equity TTM -45.58%
Profit margin 0%
Book value 0.003
Market capitalisation $12.8 million

TTM: trailing 12 months

Avecho Biotechnology share dividends

We're not expecting Avecho Biotechnology to pay a dividend over the next 12 months.

Have Avecho Biotechnology's shares ever split?

Avecho Biotechnology's shares were split on 22 April 1999.

Avecho Biotechnology share price volatility

Over the last 12 months, Avecho Biotechnology's shares have ranged in value from as little as $0.002 up to $0.0105. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Avecho Biotechnology's is 2.8012. This would suggest that Avecho Biotechnology's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avecho Biotechnology overview

Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.

Frequently asked questions

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site